Immunonutrition Supplement for Surgery-Induced Cachexia
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Surgery-induced cachexia and the associated immune suppression and inflammation in patients undergoing radical cystoprostatectomy lead to significant muscle wasting, infections, and prolonged recovery, with existing treatments failing to effectively prevent these complications.
Innovation Solution
Administration of a specialized immunonutrition supplement comprising L-arginine, omega-3 fatty acids, vitamin A, and nucleotides before and after surgery to regulate immune response, reduce myeloid-derived suppressor cells, and prevent cachexia and infections.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If radical cystoprostatectomy surgery is performed to treat invasive bladder cancer, then tumor removal and survival benefit are achieved, but surgery-induced cachexia, muscle wasting, and immune suppression occur
Solution Approach 1:
The patent applies preliminary action by administering arginine supplementation and immune-modulating nutrition before surgery to prepare the patient's immune system and prevent cachexia development. This pre-operative intervention establishes adequate arginine levels and immune function before the surgical stressor occurs, thereby preventing rather than treating the harmful effects.
Solution Approach 2:
The patent converts the harmful effect of surgery-induced arginine depletion and MDSC expansion into a benefit by using arginine supplementation to selectively inhibit MDSC function while preserving T-cell activity. The arginine intervention transforms the catabolic surgical response into an anabolic recovery process by modulating the immune response favorably.
2Reliability
If surgery duration and bowel manipulation are extended to ensure complete tumor removal, then cancer resection completeness is improved, but post-operative ileus and inflammatory response increase
Solution Approach 1:
The patent uses arginine as an intermediary substance that mediates between the surgical trauma and the immune response. Arginine supplementation acts as a molecular mediator that modulates cytokine production, reduces inflammatory signaling, and promotes gastrointestinal motility recovery without interfering with the surgical procedure itself.
3Object-affected harmful factors
If arginine supplementation is administered to prevent cachexia and modulate immune response, then muscle wasting and infections are reduced, but arginine depletion by MDSCs occurs post-surgery
Solution Approach 1:
The patent implements feedback control by monitoring arginine levels and immune response parameters to optimize supplementation dosing. The continuous administration of arginine creates a feedback loop where adequate levels are maintained despite MDSC consumption, ensuring sustained inhibition of MDSC-mediated immunosuppression while preventing cachexia development.
Data Source
AI summary
A specialized immunonutrition supplement can be administered to a surgical patient to reduce post-operative complications by restraining the expansion of myeloid-derived suppressor cells. The supplement includes one or more of L-arginine, omega-3 fatty acids, vitamin A, and dietary nucleotides, preferably all four of these compounds. The supplement is administered to the patient at least once per day for a time period extending from a pre-operative day that is three to seven days prior to a bladder surgery of the patient to a post-operative day that is three to seven days after the bladder surgery. The supplement can be administered to treat or prevent post-operative paralytic ileus in a bladder cancer patient; treat or prevent surgery-induced, inflammation-induced or cancer-induced cachexia; reduce the incidence of chronic infections resulting from expansion of myeloid-derived suppressor cells in a patient; and/or reduce mRNA expression of pro-inflammatory cytokines in a patient.